STATUTORY PRICE DISCLOSURES FOR COLORADO PRESCRIBERS
The information referenced below is intended for Colorado Prescribers. In accordance with Colorado Revised Statutes Section 12-280-308, Phathom Pharmaceuticals is disclosing wholesale acquisition cost (“WAC”) pricing information for its marketed products. WAC represents published catalogue or list prices and may not represent actual transactional prices. The price a consumer pays may differ from the price listed depending on, for example, how the customer purchases the product, the availability of discounts, the wholesaler/distributor, or other charges. Listed pricing information does not imply safety or efficacy of the product, and no comparisons should be made.
Colorado law also requires manufacturers to provide the names of generic prescription drugs from the same “therapeutic class” which is defined as, “similar drugs that have the same or similar mechanisms of action and are used to treat a specific condition.” This list does not imply that the products are interchangeable or have the same efficacy or safety. Please refer to each product’s FDA-approved label and indication for further information.
For more information on the price disclosure requirements, please contact the Colorado State Board of Pharmacy’s office:
State Board of Pharmacy
1560 Broadway, Suite 1350
Denver, CO 80202
Ph: (303) 894-7800 | Fax: (303) 894-7692 | dora_pharmacyboard@state.co.us
| Marketed Prescription Drugs | Colorado WAC Disclosure Form |
| VOQUEZNA®, VOQUEZNA® TriplePak® and VOQUEZNA® DualPak®® | Link to PDF |